Abrocitinib is more effective than dupilumab for treatment of moderate-to-severe atopic dermatitis
1. The co-primary endpoints at weeks 2 and 4 were significantly greater with abrocitinib than dupilumab. 2. Overall incidence of ...
Tag: dupilumab
Dupilumab reduces systemic glucocorticoid use in severe asthmatics
1. Glucocorticoid dependent severe asthmatics treated with dupilumab for 24 weeks used significantly lower doses of glucocorticoids while maintaining asthmatic ...
2 Minute Medicine Rewind: May 20 – May 27
May 20 - 27, 2013 In this section, we will highlight the some of the high-impact studies, updates, and analyses ...
